These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4081450)

  • 1. [New tumor-associated antigens for diagnosis and follow up of solid tumors].
    Klapdor R
    Schweiz Rundsch Med Prax; 1985 Dec; 74(50):1389-90. PubMed ID: 4081450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor-associated antigens and their importance in tumor diagnosis].
    von Kleist S
    Verh Dtsch Ges Inn Med; 1980; 86():503-6. PubMed ID: 7223038
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
    Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
    Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts in tumor antigens: their significance in future immunotherapies for tumors.
    Yang F; Yang XF
    Cell Mol Immunol; 2005 Oct; 2(5):331-41. PubMed ID: 16368059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H; Goodell V; Disis ML
    J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic applications of monoclonal antibodies to human cancer.
    Borowitz MJ; Stein RB
    Arch Pathol Lab Med; 1984 Feb; 108(2):101-5. PubMed ID: 6546490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specificity of lymphocytic reaction to tumor antigens--approaches to a cancer diagnosis in vitro?].
    Muhrer KH
    Fortschr Med; 1984 Jan; 102(3):45-8. PubMed ID: 6199270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets for active immunotherapy against pediatric solid tumors.
    Jacobs JF; Coulie PG; Figdor CG; Adema GJ; de Vries IJ; Hoogerbrugge PM
    Cancer Immunol Immunother; 2009 Jun; 58(6):831-41. PubMed ID: 19009292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can antibodies in serum predict the presence of microscopic tumors?
    Voltz R
    Neurology; 2007 Mar; 68(12):887-8. PubMed ID: 17372122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of CEA and serum glycoprotein findings in tumor diagnosis].
    Wintzer G; Koch O; Uhlenbruck G
    Internist (Berl); 1980 Apr; 21(4):181-8. PubMed ID: 6998906
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor antigens as surrogate markers and targets for therapy and vaccines.
    Dalgleish A; Pandha H
    Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rational bases for new approaches to the therapy of pediatric solid tumors: immunotherapy and gene therapy].
    Pistoia V; Prigione I; Facchetti P; Corrias MV
    Pediatr Med Chir; 1994; 16(3):219-25. PubMed ID: 7971443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against human solid tumors.
    Burtin P; Nardelli J
    Bull Cancer; 1983; 70(2):108-12. PubMed ID: 6191805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological study of a repertoire of human cancer antigens and autoantigens].
    Koroleva EP; Lagar'kova MA; Khlgatian SV; Shebzukhov IuV; Meshcheriakov AA; lichinitser MR; Nedospasov SA; Kuprash DV
    Mol Biol (Mosk); 2004; 38(2):233-8. PubMed ID: 15125227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on vaccines for solid tumors.
    Gajewski TF
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):158-9. PubMed ID: 16166944
    [No Abstract]   [Full Text] [Related]  

  • 19. [Leukocyte adherence inhibition test in tumor patients].
    Martínez Martínez B; Ordóñez Gallego A; Juárez Alonso S; González Barón M; Montero García JM
    Rev Esp Oncol; 1982; 29(4):735-42. PubMed ID: 6927371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Historical development and potential uses of tumor antigens as markers of human cancer growth.
    Gold P; Shuster J
    Cancer Res; 1980 Aug; 40(8 Pt 2):2973-6. PubMed ID: 6249494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.